📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: U3 Pharma

1.1 - Company Overview

U3 Pharma Logo

U3 Pharma

Headquarter: Germany
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of targeted cancer drug development and novel targeted therapeutics, based in Martinsried near Munich, Germany. Established in 2001, U3 Pharma develops a pipeline of targeted therapies grounded in discoveries by founder Professor Axel Ullrich. Since May 2008, the company has belonged to DAIICHI Sankyo Co., Ltd.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to U3 Pharma

ValiRx Logo

ValiRx

HQ: United Kingdom Website
  • Description: Provider of oncology therapeutics and diagnostics R&D in the United Kingdom, including VAL 101 that acts to shut down the Bcl-2 gene (a proto-oncogene) and human papilloma virus diagnostic products based on the Nucleosomics platform. Offers an evaluation pipeline for cancer projects, Inaphaea BioLabs cell-based assays in oncology and women’s health, and a partnering strategy to optimize development, minimize risk, and advance early-stage programs toward clinical development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ValiRx company profile →
Oxford Cancer Biomarkers Logo

Oxford Cancer Biomarkers

HQ: United Kingdom Website
  • Description: Provider of colorectal cancer biomarker tests, developing and commercializing a suite of diagnostics to improve the current treatment pathway; closely affiliated with the Institute of Cancer Medicine at Oxford University, where its founders lead translational cancer science research.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oxford Cancer Biomarkers company profile →
Juno Therapeutics Logo

Juno Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage immunotherapies for the treatment of cancer, formed through a unique partnership with Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center, and Seattle Children’s Research Institute to advance a broad pipeline of breakthrough immunotherapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Juno Therapeutics company profile →
Cartesian Therapeutics Logo

Cartesian Therapeutics

HQ: United States Website
  • Description: Provider of potent, safer cell therapy in and beyond oncology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cartesian Therapeutics company profile →
Morphic Therapeutics Logo

Morphic Therapeutics

HQ: United States Website
  • Description: Provider of oral integrin therapies in development to treat serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer; developing treatments for patients with immunological, fibrotic, neoplastic, and vascular diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Morphic Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for U3 Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to U3 Pharma

2.2 - Growth funds investing in similar companies to U3 Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for U3 Pharma

4.2 - Public trading comparable groups for U3 Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to U3 Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About U3 Pharma

What does U3 Pharma do?

U3 Pharma is a provider of targeted cancer drug development and novel targeted therapeutics, based in Martinsried near Munich, Germany. Established in 2001, U3 Pharma develops a pipeline of targeted therapies grounded in discoveries by founder Professor Axel Ullrich. Since May 2008, the company has belonged to DAIICHI Sankyo Co., Ltd.

Who are U3 Pharma's competitors?

U3 Pharma's competitors and similar companies include ValiRx, Oxford Cancer Biomarkers, Juno Therapeutics, Cartesian Therapeutics, and Morphic Therapeutics.

Where is U3 Pharma headquartered?

U3 Pharma is headquartered in Germany.

How many employees does U3 Pharma have?

U3 Pharma has 1,000 employees 🔒.

When was U3 Pharma founded?

U3 Pharma was founded in 2010 🔒.

What sector and industry vertical is U3 Pharma in?

U3 Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for U3 Pharma

Who are the top strategic acquirers in U3 Pharma's sector and industry

Top strategic M&A buyers and acquirers in U3 Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for U3 Pharma?

Top strategic M&A buyers groups and sectors for U3 Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in U3 Pharma's sector and industry vertical

Which are the top PE firms investing in U3 Pharma's sector and industry vertical?

Top PE firms investing in U3 Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in U3 Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in U3 Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in U3 Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to U3 Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in U3 Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for U3 Pharma?

The key public trading comparables and valuation benchmarks for U3 Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for U3 Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for U3 Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in U3 Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for U3 Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in U3 Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in U3 Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for U3 Pharma